A flow cytometric method for determination of the interferon receptor IFNAR2 subunit in peripheral blood leukocyte subsets

Journal of Pharmacological and Toxicological Methods

Volumn 50, Issue 1, 2004, Pages 59-66

  Tochizawa, Shiro ^a   Akamatsu, Seiji ^a   Sugiyama, Yoshihiro ^a   Muraguchi, Masahiro ^a   Ohmoto, Yasukazu ^a   Ono, Yukihisa ^a   Ishikawa, Hiroshi ^a   Tanigami, Akira ^a   Sumida, Takumi ^a   Mori, Toyoki ^a  

^a OTSUKA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Blood; Flow cytometry; Human; IFNAR2; Interferon; Leukocyte; Methods; Receptor; Subset

Indexed keywords

ALPHA INTERFERON; ALPHA INTERFERON RECEPTOR; ALPHA INTERFERON RECEPTOR 2; ANTIBODY; FLUORESCEIN ISOTHIOCYANATE; PHYCOERYTHRIN; UNCLASSIFIED DRUG;

ARTICLE; CHANNEL GATING; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; GRANULOCYTE; HUMAN; HUMAN CELL; LEUKOCYTE; LYMPHOCYTE; MONOCYTE; NATURAL KILLER CELL; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; STAINING;

FLOW CYTOMETRY; FLUORESCEIN-5-ISOTHIOCYANATE; HUMANS; INTERFERON-ALPHA; ION CHANNEL GATING; LEUKOCYTES; LYMPHOCYTE SUBSETS; MEMBRANE PROTEINS; PHYCOERYTHRIN; RECEPTOR, INTERFERON ALPHA-BETA; RECEPTORS, INTERFERON;

EID: 3042687326     PISSN: 10568719     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vascn.2004.02.003     Document Type: Article

References (33)

1. Appasamy R., Bryant J., Hassanein T., Van Thiel D.H., Whiteside T.L. Effects of therapy with interferon-α on peripheral blood lymphocyte subsets and NK activity in patients with chronic hepatitis C. Clinical Immunology and Immunopathology. 73:1994;350-357
2. Biron C.A., Nguyen K.B., Pien G.C., Cousens L.P., Salazar-Mather T.P. Natural killer cells in antiviral defense: Function and regulation by innate cytokines. Annual Review of Immunology. 17:1999;189-220
3. Brassard D.L., Grace M.J., Bordens R.W. Interferon-α as an immunotherapeutic protein. Journal of Leukocyte Biology. 71:2002;565-581
4. Colamonici O.R., Domanski P. Identification of a novel subunit of the type I interferon receptor localized to human chromosome 21. Journal of Biological Chemistry. 268:1993;10895-10899
5. Corssmit E.P.M., De Metz J., Sauerwein H.P., Romijn J.A. Biologic responses to IFN-α administration in humans. Journal of Interferon and Cytokine Reseach. 20:2000;1039-1047
6. Dupont S.A., Goelz S., Goyal J., Green M. Mechanisms for regulation of cellular responsiveness to human IFN-β1a. Journal of Interferon and Cytokine Reseach. 22:2002;491-501
7. Edwards B.S., Hawkins M.J., Borden E.C. Comparative in vivo and in vitro activation of human natural killer cells by two recombinant α-interferons differing in antiviral activity. Cancer Research. 44:1984;3135-3139
8. Evans T., Secher D. Kinetics of internalisation and degradation of surface-bound interferon in human lymphoblastoid cells. EMBO Journal. 3:1984;2975-2978
9. Fujiwara D., Hino K., Yamaguchi Y., Ren F., Satoh Y., Korenaga M., Okuda M., Okita K. Hepatic expression of type I interferon receptor for predicting response to interferon therapy in chronic hepatitis C patients: A comparison of immunohistohemical method vs. competitive polymerase chain reaction assay. Hepatology Research. 25:2003;337-384
10. Fukuda R., Ishimura N., Kushiyama Y., Moriyama N., Ishihara S., Nagasawa S., Miyake T., Niigaki M., Satoh S., Sakai S., Akagi S., Watanabe M., Fukumoto S. Effectiveness of interferon-alpha therapy in chronic hepatitis C is associated with the amount of interferon-alpha receptor mRNA in the liver. Journal of Hepatology. 26:1997;455-461
11. Koren H.S., Brandt C.P., Tso C.Y., Laszlo J. Modulation of natural killing activity by lymphoblastoid interferon in cancer patients. Journal of Biological Response Modifiers. 2:1983;151-165
12. Lau A.S., Hannigan G.E., Freedman M.H., Williams B.R.G. Regulation of interferon receptor expression in human blood lymphocytes in vitro and during interferon therapy. Journal of Clinical Investigation. 77:1986;1632-1638
13. Lau A.S., Read S.E., Williams B.R.G. Downregulation of interferon α but not γ receptor expression in vivo in the acquired immunodeficiency syndrome. Journal of Clinical Investigation. 82:1988;1415-1421
14. Lau J.Y.N., Sheron N., Morris A.G., Bomford A.B., Alexander G.J.M., Williams R. Interferon-α receptor expression and regulation in chronic hepatitis B virus infection. Hepatology. 13:1991;332-338
15. Lotzová E., Savary C.A. Stimulation of NK cell cytotoxic potential of normal donors by two species of recombinant alpha interferon. Journal of Interferon Research. 4:1984;201-213
16. Lotzová E., Savary C.A., Quesada J.R., Gutterman J.U., Hersh E.M. Analysis of natural killer cell cytotoxicity of cancer patients treated with recombinant interferon. Journal of the National Cancer Institute. 71:1983;903-910
17. Mathai J., Shimoda K., Banner B.F., Mori M., Bonkovsky H.L., Barnard G.F. IFN-α receptor mRNA expression in a United States sample with predominantly genotype 1a/I chronic hepatitis C liver biopsies correlates with response to IFN therapy. Journal of Interferon and Cytokine Reseach. 19:1999;1011-1018
18. Moore M., Potter M.R. Enhancement of human natural cell-mediated cytotoxicity by interferon. British Journal of Cancer. 41:1980;378-387
19. Morita K., Tanaka K., Saito S., Kitamura T., Kondo M., Sakaguchi T., Morimoto M., Sekihara H. Expression of interferon receptor genes (IFNAR1 and IFNAR2 mRNA) in the liver may predict outcome after interferon therapy in patients with chronic genotype 2a or 2b hepatitis C virus infection. Journal of Clinical Gastroenterology. 26:1998;135-140
20. Muñoz A., Carrasco L., Fresno M. Enhancement of susceptibility of HSV-1-infected cells to natural killer lysis by interferon. Journal of Immunology. 131:1983;783-787
21. Nakajima S., Kuroki T., Shintani M., Kurai O., Takeda T., Nishiguchi S., Shiomi S., Seki S., Kobayashi K. Changes in interferon receptors on peripheral blood mononuclear cells from patients with chronic hepatitis B being treated with interferon. Hepatology. 12:1990;1261-1265
22. Novick D., Cohen B., Rubinstein M. The human interferon α/β receptor: Characterization and molecular cloning. Cell. 77:1994;391-400
23. Pfeffer L.M., Dinarello C.A., Herberman R.B., Williams B.R.G., Borden E.C., Bordens R., Walter M.R., Nagabhushan T.L., Trotta P.P., Pestka S. Biological properties of recombinant α-interferons: 40th anniversary of the discovery of interferons. Cancer Research. 58:1998;2489-2499
24. Reichert T., Debruyère M., Deneys V., Töttearman T., Lydyard P., Yuksel F., Chapel H., Jewell D., Van Hove L., Linden J., Buchner L. Lymphocyte subset reference ranges in adult Caucasians. Clinical Immunology and Immunopathology. 60:1991;190-208
25. Ren F., Hino K., Yamaguchi Y., Okazaki M., Kitase A., Satoh Y., Korenaga M., Okuda M., Okita K. Hepatitis C virus infection upregulates expression of the type I interferon receptor in human peripheral blood mononuclear cells. Hepatology Research. 26:2003;15-22
26. Trinchieri G., Santoli D. Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis. Journal of Experimental Medicine. 147:1978;1314-1333
27. Uzé G., Lutfalla G., Gresser I. Genetic transfer of a functional human interferon α receptor into mouse cells: Cloning and expression of its cDNA. Cell. 60:1990;225-234
28. Yamaguchi Y., Hino K., Fujiwara D., Ren F., Katoh Y., Satoh Y., Okita K. Expression of type I interferon receptor in liver and peripheral blood mononuclear cells in chronic hepatitis C patients. Digestive Diseases and Sciences. 47:2002;1611-1617
29. Yanai Y., Sanou O., Kayano T., Ariyasu H., Yamamoto K., Yamauchi H., Ikegami H., Kurimoto M. Analysis of the antiviral activities of natural IFN-α preparations and their subtype compositions. Journal of Interferon and Cytokine Reseach. 21:2001;835-841
30. Yatsuhashi H., Fujino T., Matsumoto T., Inoue O., Koga M., Yano M. Immunohistochemical analysis of hepatic interferon alpha-beta receptor level: Relationship between receptor expression and response to interferon therapy in patients with chronic hepatitis C. Journal of Hepatology. 30:1999;995-1003
31. Yatsuhashi H., Yamasaki K., Aritomi T., Del Carmen P.M., Inoue O., Koga M., Yano M. Quantitative analysis of interferon α/β receptor mRNA in the liver of patients with chronic hepatitis C: Correlation with serum hepatitis C virus-RNA levels and response to treatment with interferon. Journal of Gastroenterology and Hepatology. 12:1997;460-467
32. Yousefi S., Escobar M.R., Gouldin C.W. A practical cytopathic effect/dye-uptake interferon assay for routine use in clinical laboratory. American Journal of Clinical Pathology. 83:1985;735-740
33. Zoon K.C., Nedden D.Z., Hu R., Arnheiter H. Analysis of the steady state binding, internalization, and degradation of human interferon-α2. Journal of Biological Chemistry. 261:1986;4993-4996